BPA CALL
ActiveHT001426FE074
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY
$564.3K
obligated · signed 3 months ago
CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM AND INFECTIOUS DISEASE MOLECULAR TESTING
Performance timeline
Start
Jul 24, 2026
End
Jul 23, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jul 23, 2027
ROCHE DIAGNOSTICS CORPORATION
Contract HT001426FE074
UEI
JDMDFEZBYH36
Parent Company
ROCHE HOLDING AG
Capabilities & Certifications
Headquarters Location
Congressional District: 07
Current Obligation
$564,340
Base + Exercised Options
$564,340
Total Ceiling Value
$564,340
Contract Type
FIRM FIXED PRICE
NAICS
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Place of Performance
Congressional District: 08
Awarding Agency
Funding Agency
Contract Vehicle
HT001424A0003
BPADepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.